Myriad Genetics, Inc. (LON:0K3W)
London · Delayed Price · Currency is GBP · Price in USD 7.48
-0.01 (-0.10%)
At close: Sep 12, 2025
Myriad Genetics Market Cap
Myriad Genetics has a market cap or net worth of 497.10 million as of September 15, 2025. Its market cap has decreased by -73.67% in one year.
Market Cap
497.10M
Enterprise Value
556.28M
Revenue
607.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.48
Market Cap Chart
Since October 6, 1995, Myriad Genetics's market cap has increased from 110.60M to 497.10M, an increase of 349.46%. That is a compound annual growth rate of 5.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 497.10M | -50.14% |
| Dec 31, 2024 | 996.94M | -25.18% |
| Dec 29, 2023 | 1.33B | 36.53% |
| Dec 30, 2022 | 975.86M | -40.05% |
| Dec 31, 2021 | 1.63B | 49.42% |
| Dec 31, 2020 | 1.09B | -28.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.89B |
| GSK plc | 59.54B |
| Haleon | 32.39B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 3.61B |
| HUTCHMED (China) | 2.23B |
| Genus | 1.65B |